Citations 132

Vesicoureteral Reflux in the Adult. III. Surgical Correction: Risks and Benefits

Journal of Urology | June 30, 2017 | Volume: 130 | Issue: 5 | Pages: 882-886

10.1016/s0022-5347(17)51549-9 | PMID 6632093

Vesicoureteral Reflux in the Adult. II. Nephropathy, Hypertension and Stones

Journal of Urology | June 30, 2017 | Volume: 130 | Issue: 1 | Pages: 41-44

10.1016/s0022-5347(17)50943-x | PMID 6864912

Vesicoureteral Reflux in the Adult. I. Factors in Pathogenesis

Journal of Urology | June 30, 2017 | Volume: 130 | Issue: 1 | Pages: 37-40

10.1016/s0022-5347(17)50942-8 | PMID 6864911

Vesicoureteral Reflux in the Adult. IV. Medical versus Surgical Management

Journal of Urology | June 30, 2017 | Volume: 132 | Issue: 5 | Pages: 882-885

10.1016/s0022-5347(17)49933-2 | PMID 6492277

Efficacy of Ganciclovir in Liver and Kidney Transplant Recipients with Severe Cytomegalovirus Infection

Journal of Urology | June 30, 2017 | Volume: 141 | Issue: 6 | Pages: 1505-1505

10.1016/s0022-5347(17)41371-1

The regulatory 1α subunit of protein kinase A modulates renal cystogenesis

American Journal of Physiology-Renal Physiology | June 14, 2017 | Volume: 313 | Issue: 3 | Pages: F677-F686

10.1152/ajprenal.00119.2017 | PMID 28615245

The failure of the polycystins (PCs) to function in primary cilia is thought to be responsible for autosomal dominant polycystic kidney disease (ADPKD). Primary cilia integrate multiple cellular signaling pathways, including calcium, cAMP, Wnt, and Hedgehog, which control cell proliferation and differentiation. It has been proposed that mutated PCs result in reduced intracellular calcium, which in turn upregulates cAMP, protein kinase A (PKA) signaling, and subsequently other proliferative signaling pathways. However, the role of PKA in ADPKD has not been directly ascertained in vivo, although the expression of the main regulatory subunit of PKA in cilia and other compartments (PKA-RIα, encoded by PRKAR1A) is increased in a mouse model orthologous to ADPKD. Therefore, we generated a kidney-specific knockout of Prkar1a to examine the consequences of constitutive upregulation of PKA on wild-type and Pkd1 hypomorphic ( Pkd1 RC ) backgrounds. Kidney-specific loss of Prkar1a induced renal cystic disease and markedly aggravated cystogenesis in the Pkd1 RC models. In both settings, it was accompanied by upregulation of Src, Ras, MAPK/ERK, mTOR, CREB, STAT3, Pax2 and Wnt signaling. On the other hand, Gli3 repressor activity was enhanced, possibly contributing to hydronephrosis and impaired glomerulogenesis in some animals. To assess the relevance of these observations in humans we looked for and found evidence for kidney and liver cystic phenotypes in the Carney complex, a tumoral syndrome caused by mutations in PRKAR1A. These observations expand our understanding of the pathogenesis of ADPKD and demonstrate the importance of PRKAR1A highlighting PKA as a therapeutic target in ADPKD.
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials

Current Hypertension Reviews | May 2, 2017 | Volume: 13 | Issue: 2 | Pages: No page available

10.2174/1573402113666170427142815 | PMID 28460625

Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial

Nephrology Dialysis Transplantation | April 20, 2017 | Volume: 33 | Issue: 4 | Pages: 645-652

10.1093/ndt/gfx188 | PMID 28992127

Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial

The Journal of Clinical Pharmacology | February 20, 2017 | Volume: 57 | Issue: 7 | Pages: 906-917

10.1002/jcph.880 | PMID 28218410

Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial

Nephrology Dialysis Transplantation | February 18, 2017 | Volume: 33 | Issue: 3 | Pages: 477-489

10.1093/ndt/gfx043 | PMID 28379536